Adderall XR adult indication
Executive Summary
FDA approves Shire's attention deficit hyperactivity disorder treatment Adderall XR (amphetamine) for use in adults Aug. 11...
You may also be interested in...
Shire Adderall XR Sales Suspended In Canada; FDA Stands By “Black Box”
Differences between FDA and Health Canada's regulatory responses to adverse event reports for Adderall XR are likely to raise more questions about FDA's drug safety review process
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.